Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-56136379 in Chronic Hepatitis B (Phase II)
CTR20181225Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bersacapavir in Chronic Hepatitis B (CHB), sponsored by Janssen Pharmaceutical. Started Aug 2018; status: completed.
02
Drugs
bersacapavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20181225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181225.